QIPT

MKT CAP:$162M

Quipt Home Medical Corp.

Market Cap

$162M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$3.65+$0.12 (+3.40%)

Mar 23, 2026

Company Details

Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. The company also offers management of various chronic disease states focusing on patients with hea...

CEO

Gregory John Crawford

IPO Date

Aug 10, 2010

Website

quipthomemedical.com

Key Metrics TTM

Revenue

$267M

+11.7% YoY

Net Income

-$9M

EPS (Diluted)

-$0.21

Free Cash Flow

$28M

Revenue / Share

$6.13

Gross Margin

97.1%

Operating Margin

0.2%

Net Margin

-3.3%

FCF Margin

10.4%

P/S

0.6x

P/E

—

Earnings Reports

Q1 2026

Feb 9, 2026

$81M+32.0%EPS -$0.03

FY 2025

Dec 15, 2025

$341M+38.8%EPS -$0.25

Q4 2025

Dec 15, 2025

$68M+28.3%EPS -$0.08

Q2 2025

May 12, 2025

$57MEPS -$0.07

Q1 2025

Feb 10, 2025

$61MEPS -$0.03

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q2 16	$19M	$13M	-$7M
Q2 17	$19M	$15M	$665.7K
Q4 17	$11M	$10M	-$6M
Q2 19	$11M	$8M	$315.7K
Q4 22	$40M	$31M	$850.0K
Q2 23	$58M	$43M	$1M
Q3 23	$60M	$44M	$170.0K
Q4 23	$63M	$46M	$1M
Q3 24	$64M	$47M	$390.0K
Q4 24	$53M	$35M	-$2M
Q1 25	$61M	$44M	$448.0K
Q2 25	$57M	$56M	-$999.0K
Q4 25	$68M	$81M	-$1M
Q1 26	$81M	$79M	$3M

Valuation

Quarter	P/S	P/E
Q2 16	—	—
Q2 17	—	—
Q4 17	—	—
Q2 19	2.7x	—
Q4 22	2.0x	—
Q2 23	1.3x	—
Q3 23	1.0x	—
Q4 23	0.7x	—
Q3 24	0.7x	—
Q4 24	0.7x	—
Q1 25	0.7x	—
Q2 25	0.7x	—
Q4 25	0.7x	—
Q1 26	0.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q2 16	-$3M	-$3M
Q2 17	$5M	$4M
Q4 17	$1M	-$638.7K
Q2 19	-$3M	-$4M
Q4 22	$5M	$4M
Q2 23	$10M	$6M
Q3 23	$12M	$12M
Q4 23	$13M	$11M
Q3 24	$14M	$10M
Q4 24	$7M	$3M
Q1 25	$9M	$6M
Q2 25	$9M	$7M
Q4 25	$10M	$8M
Q1 26	$9M	$7M

Capital Expenditures

Quarter	CapEx
Q2 16	$105.1K
Q2 17	$968.3K
Q4 17	$2M
Q2 19	$208.5K
Q4 22	$1M
Q2 23	$4M
Q3 23	$22.0K
Q4 23	$2M
Q3 24	$4M
Q4 24	$3M
Q1 25	$4M
Q2 25	$2M
Q4 25	$2M
Q1 26	$2M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q4 22	+111.0%	+49.5%
Q2 23	+208.7%	+212.8%
Q3 23	+460.0%	+264.7%
Q4 23	+448.6%	+454.6%
Q3 24	+59.5%	+62.0%
Q4 24	-9.4%	-4.1%
Q1 25	+1.8%	+1.4%
Q2 25	-8.2%	-5.0%
Q4 25	+5.6%	+8.5%
Q1 26	+53.9%	+44.1%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q2 16	$2M	8.8%
Q2 17	-$2M	-11.6%
Q4 17	$294.1K	2.7%
Q2 19	$263.8K	2.3%
Q4 22	$897.0K	2.2%
Q2 23	$1M	2.2%
Q3 23	$2M	3.4%
Q4 23	$1M	2.2%
Q3 24	$483.0K	0.8%
Q4 24	$330.0K	0.6%
Q1 25	$207.0K	0.3%
Q2 25	$298.0K	0.5%
Q4 25	$1M	2.1%
Q1 26	$982.0K	1.2%

OpEx Breakdown

Quarter	G&A	S&M
Q2 16	$10M	$404.2K
Q2 17	$2M	$137.5K
Q4 17	$13M	$339.0K
Q2 19	$5M	$77.2K
Q4 22	$14M	$1M
Q2 23	$21M	$1M
Q3 23	$21M	$1M
Q4 23	$23M	$1M
Q3 24	$22M	$1M
Q4 24	$23M	$1M
Q1 25	$22M	$1M
Q2 25	$21M	$1M
Q4 25	$25M	$1M
Q1 26	$31M	$2M

War Chest

Quarter	Cash	Short-term Investments	Total
Q2 22	$19M	$0	$19M
Q3 22	$19M	$0	$19M
Q4 22	$9M	$0	$9M
Q1 23	$2M	$0	$2M
Q2 23	$2M	$0	$2M
Q3 23	$20M	$0	$20M
Q4 23	$17M	$0	$17M
Q1 24	$18M	$0	$18M
Q2 24	$15M	$0	$15M
Q3 24	$14M	$0	$14M
Q4 24	$16M	$0	$16M
Q1 25	$15M	$0	$15M
Q2 25	$17M	$0	$17M
Q3 25	$11M	$0	$11M
Q4 25	$13M	$0	$13M
Q1 26	$11M	$0	$11M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q2 16	18M	—	—
Q2 17	20M	+10.3%	—
Q4 17	21M	+1.7%	—
Q2 19	21M	+1.1%	—
Q4 22	38M	+82.7%	+107.3%
Q2 23	36M	-6.0%	+76.6%
Q3 23	41M	+13.2%	+96.6%
Q4 23	44M	+8.9%	+111.7%
Q3 24	43M	-3.6%	+11.7%
Q4 24	43M	+1.1%	+20.2%
Q1 25	43M	-0.0%	+6.2%
Q2 25	43M	+0.2%	-2.3%
Q4 25	43M	+0.6%	+1.9%
Q1 26	44M	+0.4%	+1.2%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q2 16	—	—
Q2 17	—	—
Q4 17	—	—
Q2 19	—	—
Q4 22	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	—	—
Q3 24	—	—
Q4 24	$43.9K	1K
Q1 25	$51.2K	1K
Q2 25	$47.8K	1K
Q4 25	$42.2K	2K
Q1 26	$50.6K	2K

Revenue / Employee